| CAPAX | VTMFX | CAPAX / VTMFX | |
| Total Expense Ratio | 0.90 | 0.05 | 1,800% |
| Annual Report Gross Expense Ratio | 1.12 | 0.05 | 2,240% |
| Fund Existence | 38 years | 32 years | - |
| Gain YTD | 5.365 | 3.413 | 157% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1500 | 10000 | 15% |
| Min. Initial Investment IRA | 250 | N/A | - |
| Net Assets | 669M | 12.3B | 5% |
| Annual Yield % from dividends | 3.45 | 2.22 | 156% |
| Returns for 1 year | 11.20 | 8.85 | 127% |
| Returns for 3 years | 36.27 | 30.02 | 121% |
| Returns for 5 years | 28.46 | 28.44 | 100% |
| Returns for 10 years | 76.03 | 93.00 | 82% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SPFCX | 20.31 | 0.25 | +1.25% |
| PGIM Jennison Focused Growth C | |||
| WMLIX | 36.25 | 0.22 | +0.61% |
| Wilmington Large-Cap Strategy Instl | |||
| MSACX | 21.73 | 0.10 | +0.46% |
| Morgan Stanley Inst Passport ovrs eq I | |||
| RALOX | 11.74 | -0.05 | -0.42% |
| Lazard Real Assets Open | |||
| SHISX | 61.73 | -0.68 | -1.09% |
| BlackRock Health Sciences Opps Svc | |||